Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen and Exemestane Trial
ISRCTN66949472Phase 3Completed
- Sponsor
- International Breast Cancer Study Group
- Start
- Nov 2003
- Modality
- Small Molecules, Peptides
01
Overview
Phase 3, randomised, open-label trial in breast cancer comparing Triptorelin + tamoxifen with Triptorelin + exemestane (2 arms). Primary endpoint: Disease-free survival. Started Nov 2003; status: completed.
02
Drugs
tamoxifenexemestanetriptorelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN66949472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN66949472.